Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
FDA adcomm votes 11-2 to expand Roche's Polivy label in DLBCL
3 years ago
Pharma
FDA+
Biden budget wants to more than double number of negotiated drugs under Medicare, and eliminate hepatitis C
3 years ago
FDA+
Law
Eli Lilly asks ‘what if’ in first Mounjaro consumer campaign for type 2 diabetes
3 years ago
Pharma
Marketing
Alnylam expands RNAi commercialization deal in Europe
3 years ago
Pharma
Marketing
Pharma marketers change the advertising channel from broadcast to streaming TV, media experts weigh in
3 years ago
Marketing
FDA makes rare 'misinformation' comment on Lucira's EUA for its at-home Covid-19 and flu test
3 years ago
Pharma
FDA+
Democrats look to cap insulin price at $20 per vial
3 years ago
Pharma
Simultaneous advice from FDA and EMA? Very few companies go that route with new drugs, review finds
3 years ago
FDA+
Manufacturing roundup: GenSight terminates batch of gene therapy; Evonik opens lipid production site in Germany
3 years ago
Manufacturing
Apotex issues recall of eye treatment over cracked bottle caps
3 years ago
Pharma
FDA+
Sandoz to expand its presence in Slovenia with new $400M plant
3 years ago
Manufacturing
UMass medical school’s manufacturing unit lays off 26 employees
3 years ago
People
Manufacturing
AstraZeneca touts PhIII event-free survival win with Imfinzi
3 years ago
R&D
Coherus BioSciences lays off 20% of staff, while antimicrobial biotech makes deeper cuts
3 years ago
People
Neoleukin sends 70% of staff packing as IL-2 biotech searches for sale or other exit
3 years ago
People
Fresh Tracks considers options to stay afloat and develop autoimmune candidates
3 years ago
R&D
Flagship biotech 'Rings' in $85M+ for next-gen gene therapy effort
3 years ago
Financing
Cell/Gene Tx
Tagrisso reaches OS endpoint in PhIII EGFR-mutated lung cancer trial
3 years ago
R&D
Ten years later, Lilly's long-term Alzheimer's trial of solanezumab has definitively failed
3 years ago
R&D
Pharma
Short supply of commonly used cancer drugs raises concerns among hospital pharmacists
3 years ago
Pharma
Manufacturing
ALS biotech QurAlis gets $88M boost from four pharmas for pair of PhI studies
3 years ago
Financing
Startups
Industry advocates urge Senate health committee leaders to support antimicrobial pricing reform
3 years ago
Pharma
FDA raises questions in adcomm briefing docs for Roche's Polivy label expansion
3 years ago
Pharma
FDA+
Organon doubles down on mission to prevent unplanned pregnancies with $30M investment
3 years ago
Pharma
Marketing
First page
Previous page
364
365
366
367
368
369
370
Next page
Last page